Home

Bioworkshops sell "Tezepelumab"

Basic Information

215
16
2
4.3(39)

Trade Type

Sell

Product Name

Tezepelumab

Manufacturer(s)

Specifications

  • Expression System: Developed from an optimized, DMF-filed mammalian cell line delivering consistently high titer productivity for biosimilar manufacturing
  • Application: Anti-TSLP monoclonal antibody biosimilar candidate targeting severe asthma and related immune/respiratory indications
  • Regulatory Status: Analytical comparability demonstrated to the reference product (tezepelumab, originally approved in the United States on 2021-12-17), supporting regulatory and clinical acceptance
  • Certification Standard: DMF filing in place for the production cell line, supporting global regulatory readiness and streamlined submissions

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product